pre-IPO PHARMA

COMPANY OVERVIEW

Akouos is developing precision genetic medicines to restore and preserve hearing in genetically-defined patient populations.


LOCATION

  • Boston, MA, USA

  • THERAPEUTIC AREAS

  • Neurological Disorders

  • WEBSITE

    https://www.akouos.com


    CAREER WEBSITE

    https://www.akouos.com


    SOCIAL MEDIA


    INVESTORS

    5am-ventures nea novartis-venture-fund partners-innovation-fund ra-capital sofinnova-ventures


    PRESS RELEASES


    May 11, 2020

    Akouos to Present Data from Inner Ear Gene Therapy Platform at 23rd ASGCT Annual Meeting


    Mar 3, 2020

    Akouos Closes $105 Million Series B Financing


    Jan 24, 2020

    Akouos Announces New Data at the Association for Research in Otolaryngology Midwinter Meeting


    Jan 9, 2020

    Akouos Announces Senior Leadership Team Appointments


    Oct 24, 2019

    Akouos Appoints Rabia Gurses Ozden, M.D., as Chief Development Officer


    For More Press Releases


    Google Analytics Alternative